Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Bedlack

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Handbook of Experimental Pharmacology|September 1, 2011
HDACs in skeletal muscle remodeling and neuromuscular diseaseBryan J Simmons, Todd J Cohen, Richard Bedlack, et al.
Neurorehabilitation|September 28, 2015
Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosisSabrina Paganoni, Chafic Karam, Nanette Joyce, et al.
Plos One|September 26, 2017
Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic diseaseNisha Mukherjee, Shan McBurney-Lin, Anthony Kuo, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 26, 2020
Engaging ALS patients and caregivers (the ALS research ambassadors) to help design the REFINE-ALS biomarker studyJames D Berry, Richard Bedlack, Debra Mathews, et al.
The American Journal of Hospice & Palliative Care|September 10, 2014
Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based ReviewChafic Y Karam, Sabrina Paganoni, Nanette Joyce, et al.
Frontiers in Neurology|February 16, 2026
Toward a "green" brain health agenda: establishing short- and long-term goals for the field of neurology in a changing climateEsme D Trahair, Trisha Dalapati, Danelle Levinson, et al.
Scientific Reports|August 30, 2022
Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onsetFrances Theunissen, Ryan S Anderton, Frank L Mastaglia, et al.
Annals of Neurology|November 6, 2024
The Scientific and Therapeutic Rationale for Off-Label Treatments in Amyotrophic Lateral SclerosisRichard Bedlack, Xiaoyan Li, Baggio Angelo Evangelista, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 30, 2021
ALSUntangled #62: vitamin CRichard Bedlack, Paul Barkhaus, Greg Carter, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 22, 2017
A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013D Kevin Horton, Shannon Graham, Reshma Punjani, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Handbook of Experimental Pharmacology|September 1, 2011
HDACs in skeletal muscle remodeling and neuromuscular diseaseBryan J Simmons, Todd J Cohen, Richard Bedlack, et al.
Neurorehabilitation|September 28, 2015
Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosisSabrina Paganoni, Chafic Karam, Nanette Joyce, et al.
Plos One|September 26, 2017
Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic diseaseNisha Mukherjee, Shan McBurney-Lin, Anthony Kuo, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 26, 2020
Engaging ALS patients and caregivers (the ALS research ambassadors) to help design the REFINE-ALS biomarker studyJames D Berry, Richard Bedlack, Debra Mathews, et al.
The American Journal of Hospice & Palliative Care|September 10, 2014
Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based ReviewChafic Y Karam, Sabrina Paganoni, Nanette Joyce, et al.
Frontiers in Neurology|February 16, 2026
Toward a "green" brain health agenda: establishing short- and long-term goals for the field of neurology in a changing climateEsme D Trahair, Trisha Dalapati, Danelle Levinson, et al.
Scientific Reports|August 30, 2022
Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onsetFrances Theunissen, Ryan S Anderton, Frank L Mastaglia, et al.
Annals of Neurology|November 6, 2024
The Scientific and Therapeutic Rationale for Off-Label Treatments in Amyotrophic Lateral SclerosisRichard Bedlack, Xiaoyan Li, Baggio Angelo Evangelista, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 30, 2021
ALSUntangled #62: vitamin CRichard Bedlack, Paul Barkhaus, Greg Carter, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 22, 2017
A spatial analysis of amyotrophic lateral sclerosis (ALS) cases in the United States and their proximity to multidisciplinary ALS clinics, 2013D Kevin Horton, Shannon Graham, Reshma Punjani, et al.
Pageof 8